6th Jun 2007 07:01
Gyrus Group PLC06 June 2007 GYRUS GROUP PLC ("The Company") Director / PDMR Shareholding The Company, a leading supplier of medical devices to reduce trauma andcomplications in surgery, has received notifications from its Chairman, BrianSteer (former Executive Chairman), and the Chief Financial Officer, Simon Shaw,that on 5th June 2007 they exercised options over 680,850 shares of 1p each asfollows: Brian Steer 586,066 options over ordinary shares issued at an average exercise price of£2.403 per share Simon Shaw 94,784 options over ordinary shares issued at an average exercise price of£1.975 per share Subsequently, all 680,850 shares arising from the exercise were sold at anaverage price of £4.836 per share. After the sale, Brian Steer retains an interest in approximately 1,079,672shares, representing approximately 0.7% of the Company's issued ordinary sharecapital as a result of option and LTIP schemes, which are subject to performanceconditions, and direct investments by him. After the sale, Simon Shaw retains an interest in approximately 482,189 shares,representing approximately 0.3% of the Company's issued ordinary share capital,as a result of option and LTIP schemes, which are subject to performanceconditions, and direct investments by him. This notice is given in fulfilment of the obligation under DTR 3.1.4. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
GYG.L